Abstract
The goal of this study was to compare brain structure between individuals with generalized anxiety disorder (GAD) and healthy controls. Previous studies have generated inconsistent findings, possibly due to small sample sizes, or clinical/analytic heterogeneity. To address these concerns, we combined data from 28 research sites worldwide through the ENIGMA-Anxiety Working Group, using a single, pre-registered mega-analysis. Structural magnetic resonance imaging data from children and adults (5–90 years) were processed using FreeSurfer. The main analysis included the regional and vertex-wise cortical thickness, cortical surface area, and subcortical volume as dependent variables, and GAD, age, age-squared, sex, and their interactions as independent variables. Nuisance variables included IQ, years of education, medication use, comorbidities, and global brain measures. The main analysis (1020 individuals with GAD and 2999 healthy controls) included random slopes per site and random intercepts per scanner. A secondary analysis (1112 individuals with GAD and 3282 healthy controls) included fixed slopes and random intercepts per scanner with the same variables. The main analysis showed no effect of GAD on brain structure, nor interactions involving GAD, age, or sex. The secondary analysis showed increased volume in the right ventral diencephalon in male individuals with GAD compared to male healthy controls, whereas female individuals with GAD did not differ from female healthy controls. This mega-analysis combining worldwide data showed that differences in brain structure related to GAD are small, possibly reflecting heterogeneity or those structural alterations are not a major component of its pathophysiology.
Original language | English |
---|---|
Article number | 502 |
Journal | Translational Psychiatry |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2021 |
Externally published | Yes |
Funding
Funders | Funder number |
---|---|
Robert and Janice McNair Foundation | |
Fresenius Medical Care North America | |
Federal State of Mecklenburg-West Pomerania | |
Kairos Venture Capital, Inc. | |
FIPE-HCPA | |
Social Ministry of the Federal State of Mecklenburg-West Pomerania | |
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | |
Fundação de Amparo à Pesquisa do Estado de São Paulo | |
Ministry of Cultural Affairs | |
Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica | |
Allergan Foundation | |
European Research Council | |
Biogen, Inc. | |
SA MRC | |
National Institute of Mental Health | R01MH065413, K23MH086686, K23MH100259, K99MH117274, R01MH108509, T32MH014654, T32MH100019, R01MH116147, R01MH117600, R01MH117601, ZIA-MH-002782, K23MH109983, K23MH114023, R01MH101486, R01MH101497, K24MH064122 |
National Science Foundation | CBET0954643 |
U.S. Department of Veterans Affairs | VHA5I01CX000994, I01CX000994 |
Hartford HealthCare Research Funding Initiative | 129522 |
ENIGMA World Aging Center | R56 AG058854 |
Deutsche Forschungsgemeinschaft | BE 3809/8-1, 44541416 – TRR 58, R01MH101486-04, R01MH117601, C0, SFB/TRR 58: C06 |
ENIGMA Sex Differences Initiative | R01 MH116147 |
Developmental Neuroscience and Child Psychopathology | K23MH109983, T32 MH100019 |
National Institute on Drug Abuse | U01DA041117, U01DA041106, U01DA041028, U01DA041148, U24DA041147, U01DA041048, U01DA041025, U24DA041123, U01DA041156, U01DA041134, U01DA041089, U01DA041022, U01DA041120, U01DA041174, U01DA041093 |
Ministero della Salute | K23MH100259, GR-2018-12367789, R01 MH 108509, C06, K23 MH 086686, RF-2016-02364582 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 019.201SG.022 |
Office of Naval Research | GR-2010-2312442, K99MH117274, T32 MH014654, K23MH114023, N000140410051 |
National Institutes of Health | R01MH11760 |
National Institute of Biomedical Imaging and Bioengineering | U54EB020403 |
Bundesministerium für Bildung und Forschung | 01ZZ0403, and 01ZZ0403, 01ZZ0103, 01ZZ9603 |
Conselho Nacional de Desenvolvimento Científico e Tecnológico | 304829/2013-7, ZIA-MH-002798, 475293/2012-6 |
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul | R01MH101497 |
National Institute on Aging | R56AG058854 |